- Report
- August 2021
- 131 Pages
Global
From €5730EUR$5,950USD£4,928GBP
- Report
- April 2022
- 150 Pages
Global
From €5730EUR$5,950USD£4,928GBP
- Report
- January 2018
- 195 Pages
Global
From €4021EUR$4,175USD£3,458GBP
- Report
- November 2020
- 553 Pages
Global
From €3996EUR$4,150USD£3,437GBP
- Report
- April 2023
- 150 Pages
Global
From €4671EUR$4,850USD£4,017GBP
- Report
- October 2019
- 85 Pages
Global
From €1820EUR$1,890USD£1,565GBP
From €3371EUR$3,500USD£2,899GBP
From €3371EUR$3,500USD£2,899GBP
- Report
- October 2023
- 90 Pages
Israel
From €3371EUR$3,500USD£2,899GBP
- Report
- October 2023
- 79 Pages
Malaysia
From €3371EUR$3,500USD£2,899GBP
- Report
- October 2023
- 88 Pages
Malaysia
From €3371EUR$3,500USD£2,899GBP
- Report
- October 2023
- 89 Pages
Malaysia
From €3371EUR$3,500USD£2,899GBP
- Report
- August 2023
- 77 Pages
Canada
From €3371EUR$3,500USD£2,899GBP
- Report
- August 2023
- 76 Pages
Egypt
From €3371EUR$3,500USD£2,899GBP
- Report
- August 2023
- 79 Pages
Canada
From €3371EUR$3,500USD£2,899GBP
- Report
- August 2023
- 78 Pages
Israel
From €3371EUR$3,500USD£2,899GBP
- Report
- August 2023
- 78 Pages
Egypt
From €3371EUR$3,500USD£2,899GBP
- Report
- January 2023
- 87 Pages
Global
From €4767EUR$4,950USD£4,100GBP
- Report
- April 2024
- 85 Pages
India
From €3371EUR$3,500USD£2,899GBP
- Report
- July 2022
- 100 Pages
Global
From €2648EUR$2,750USD£2,278GBP
The Implantable Cardioverter Defibrillator (ICD) market is a segment of the Cardiovascular Devices market. ICDs are medical devices used to treat life-threatening arrhythmias, or abnormal heart rhythms. They are implanted in the chest and monitor the heart's electrical activity. When an abnormal rhythm is detected, the device delivers an electrical shock to restore normal rhythm. ICDs are used to treat ventricular tachycardia and ventricular fibrillation, two of the most common causes of sudden cardiac death.
The ICD market is driven by the increasing prevalence of cardiovascular diseases, technological advancements, and the growing demand for minimally invasive treatments. The market is expected to grow at a steady rate over the forecast period.
Some of the major players in the ICD market include Medtronic, Abbott, Boston Scientific, Biotronik, LivaNova, and Sorin Group. Show Less Read more